News Image

Wednesday's session: top gainers and losers

By Mill Chart

Last update: Sep 28, 2022

Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.

Today's top gainers

TickerChangeComment
PRTA75.4%PROTHENA CORP PLC's (NASDAQ:PRTA) shares rose 75.4% to $54.25. In the last 6 months the stock lost 20.81%.
SOBR62.96%SOBR SAFE INC (NASDAQ:SOBR) rose 62.96% to $2.2 during Wednesday's after hours session. The stock is trading 27.96% higher than a month ago.
BTRS60.4%BTRS HOLDINGS INC-CL 1's (NASDAQ:BTRS) stock price increased by 60.4% to $9.26. Earlier today the company had a press release: BTRS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of BTRS Holdings Inc. Is Fair to Shareholders.
FNGR57.55%FINGERMOTION INC's (NASDAQ:FNGR) stock price is advancing with 57.55% to a price of $1.67. The stock is trading 21.54% lower than 3 months ago.
BIIB39.02%BIOGEN INC's (NASDAQ:BIIB) shares rose 39.02% to $274.97. In the last year the stock lost 30.34%.
BEAT33.43%HEARTBEAM INC's (NASDAQ:BEAT) shares rose 33.43% to $3.59 during Wednesday's session. Earlier today the company had a press release: HeartBeam Granted Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG).
QTRX32.36%QUANTERIX CORP's (NASDAQ:QTRX) shares rose 32.36% to $10.67 during Wednesday's session. The stock is trading 52.0% lower than 3 months ago.
KLXE28.79%KLX ENERGY SERVICES HOLDING's (NASDAQ:KLXE) stock price is advancing with 28.79% to a price of $6.89. The stock is trading 35.15% lower than a month ago.
STIM24.37%NEURONETICS INC's (NASDAQ:STIM) shares rose 24.37% to $2.96 during Wednesday's session. The stock is trading 38.66% lower than a month ago.
TOPS24.37%TOP SHIPS INC (NASDAQ:TOPS) rose 24.37% to $2.91 during Wednesday's after hours session. Shareholders saw the stock price going 59.84% lower in the past month.

To see the full list of top gainers you can use our top gainers screener.

Top losers

TickerChangeComment
PHAS-65.01%PHASEBIO PHARMACEUTICALS INC's (NASDAQ:PHAS) stock price is declining with 65.01% to a price of $0.27. In the last month the share price dropped with 32.74%.
MNMD-50.41%MIND MEDICINE MINDMED INC's (NASDAQ:MNMD) stock price is declining with 50.41% to a price of $3.04. In the last month the stock lost 49.04%.
IBIO-35.41%IBIO INC's (NYSEARCA:IBIO) stock price decreased by 35.41% to $0.2. In the last 3 months the stock gained 21.54%.
NA-33.02%NANO LABS LTD-ADR's (NASDAQ:NA) stock price decreased by 33.02% to $2.13. A press release (Nano Labs Ltd Announces Pricing of Public Offering of American Depositary Shares) was released yesterday.
HLBZW-31.14%HELBIZ INC-CW24's (NASDAQ:HLBZW) shares fell 31.14% to $0.07 during Wednesday's session. In the last 6 months the share price dropped with 65.67%.
GROV-25.71%GROVE COLLABORATIVE HOLDINGS's (NYSE:GROV) stock price is declining with 25.71% to a price of $2.98. Yesterday the company had a press release: Grove Co. Continues Retail Expansion with Entry Into Thousands of More Stores.
SONX-22.75%SONENDO INC's (NYSE:SONX) stock price is declining with 22.75% to a price of $1.29. In the last month the share price increased with 41.53%.
ALLG-22.62%ALLEGO NV's (NYSE:ALLG) stock price is declining with 22.62% to a price of $4.55. The stock is trading 51.55% higher than a month ago.
REVBW-21.82%REVELATION BIOSC -CW27's (NASDAQ:REVBW) shares fell 21.82% to $0.04. In the last month the stock lost 38.43%.
LYLT-21.71%LOYALTY VENTURES INC's (NASDAQ:LYLT) shares fell 21.71% to $1.37 during Wednesday's session. The stock is trading 21.88% lower than a month ago.

For the full top loser list go to our top losers screener.

Back

BIOGEN INC

NASDAQ:BIIB (4/26/2024, 7:00:00 PM)

After market: 208.5 -0.4 (-0.19%)

208.9

+6.44 (+3.18%)

BIIB News

News Image2 days ago - Market News VideoBIIB June 7th Options Begin Trading
News Image3 days ago - Investor's Business DailyStock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review

Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser.

News Image3 days ago - Biogen Inc.Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®

CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing TOFIDENCE™ to the reference product ROACTEMRA® ...

News Image4 days ago - The Motley FoolWhy Biogen Stock Leaped Nearly 5% Higher Today

The company came out swinging with its first set of quarterly earnings for this year.

News Image4 days ago - Market News VideoNotable Wednesday Option Activity: BIIB, ABNB, HPQ
News Image4 days ago - ChartmillIn today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Wednesday's session.

Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below.

News Image4 days ago - The Motley FoolBiogen (BIIB) Q1 2024 Earnings Call Transcript

BIIB earnings call for the period ending March 31, 2024.

News Image4 days ago - ChartmillWhich S&P500 stocks are moving on Wednesday?

Wednesday's session: top gainers and losers in the S&P500 index

News Image5 days ago - InvestorPlaceBIIB Stock Earnings: Biogen Beats EPS, Misses Revenue for Q1 2024

BIIB stock results show that Biogen beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

News Image5 days ago - ChartmillThese S&P500 stocks are moving in today's pre-market session

Curious about the S&P500 stocks that are showing activity before the opening bell on Wednesday?

News Image5 days ago - InvezzBiogen Q1 2024 results surpass expectation despite revenue decline

Biogen Inc. (NASDAQ: BIIB), a leading biotechnology company, has released its Q1 2024 financial results, showcasing resilience and strategic growth despite facing revenue challenges. In the first quarter of 2024, Biogen reported a revenue of $2.29 billion, which slightly missed expectations by $30 million. However, the company demonstrated a meaningful improvement in both gross and […]

News Image5 days ago - Investor's Business DailyTwo Notable Biogen Drugs Walloped Sales Forecasts. Will It Be Enough To Reverse Biogen Stock's Decline?

Biogen shares have lost nearly 40% of their value since last June. Could two key sales beats help revive shares?

BIIB Links
Follow us for more